Please use this identifier to cite or link to this item: http://hdl.handle.net/1822/51517

TitleA novel microduplication of ARID1B: Clinical, genetic, and proteomic findings
Author(s)Seabra, Catarina M.
Szoko, Nicholas
Erdin, Serkan
Ragavendran, Ashok
Stortchevoi, Alexei
Maciel, P.
Lundberg, Kathleen
Schlatzer, Daniela
Smith, Janice
Talkowski, Michael E.
et. al.
KeywordsARID1B
Chromatin
Development
Intellectual disability
Proteome
Proteomic
Regulation
SWI/SNF
SWI/SNF-A
SWI
SNF
Issue date21-Sep-2017
PublisherWiley
JournalAmerican Journal of Medical Genetics Part A
CitationSeabra, C. M., Szoko, N., Erdin, S., Ragavendran, A., Stortchevoi, A., Maciel, P., ... & Gusella, J. F. (2017). A novel microduplication of ARID1B: Clinical, genetic, and proteomic findings. American Journal of Medical Genetics Part A, 173(9), 2478-2484
Abstract(s)Genetic alterations of ARID1B have been recently recognized as one of the most common mendelian causes of intellectual disability and are associated with both syndromic and non-syndromic phenotypes. The ARID1B protein, a subunit of the chromatin remodeling complex SWI/SNF-A, is involved in the regulation of transcription and multiple downstream cellular processes. We report here the clinical, genetic, and proteomic phenotypes of an individual with a unique apparent de novo mutation of ARID1B due to an intragenic duplication. His neurodevelopmental phenotype includes a severe speech/language disorder with full scale IQ scores 78-98 and scattered academic skill levels, expanding the phenotypic spectrum of ARID1B mutations. Haploinsufficiency of ARID1B was determined both by RNA sequencing and quantitative RT-PCR. Fluorescence in situ hybridization analysis supported an intragenic localization of the ARID1B copy number gain. Principal component analysis revealed marked differentiation of the subject's lymphoblast proteome from that of controls. Of 3426 proteins quantified, 1014 were significantly up- or down-regulated compared to controls (q<0.01). Pathway analysis revealed highly significant enrichment for canonical pathways of EIF2 and EIF4 signaling, protein ubiquitination, tRNA charging and chromosomal replication, among others. Network analyses revealed down-regulation of: (1) intracellular components involved in organization of membranes, organelles, and vesicles; (2) aspects of cell cycle control, signal transduction, and nuclear protein export; (3) ubiquitination and proteosomal function; and (4) aspects of mRNA synthesis/splicing. Further studies are needed to determine the detailed molecular and cellular mechanisms by which constitutional haploinsufficiency of ARID1B causes syndromic and non-syndromic developmental disabilities.
TypeArticle
URIhttp://hdl.handle.net/1822/51517
DOI10.1002/ajmg.a.38327
ISSN1552-4833
Publisher versionhttp://onlinelibrary.wiley.com/doi/10.1002/ajmg.a.38327/full
Peer-Reviewedyes
AccessOpen access
Appears in Collections:ICVS - Artigos em Revistas Internacionais com Referee

Files in This Item:
File Description SizeFormat 
seabra_cm_2017_arid1b_dup.pdf706 kBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID